Myelomastocytic Blast Cell Crisis in Resistant Tyrosine Kinase Inhibitor Chronic Myelogenous Leukemia: Case Report and Review of Literature: CML‐143

[1]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[2]  C. Çehreli,et al.  Mast cell leukemia associated with undefined morphology and chronic basophilic leukemia , 2014, BMC Hematology.

[3]  C. Tzeng,et al.  Mast cell leukemia: an extremely rare disease. , 2014, Journal of the Chinese Medical Association : JCMA.

[4]  H. Arima,et al.  Monocytic crisis of chronic myeloid leukemia in the era of tyrosine kinase inhibitor. , 2013, Journal of clinical and experimental hematopathology : JCEH.

[5]  B. Esmaeli,et al.  Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Hehlmann,et al.  Treatment of chronic myeloid leukemia in blast crisis , 2008, Haematologica.

[7]  T. Brümmendorf,et al.  Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase , 2008, Leukemia.

[8]  H. Dombret,et al.  Efficacy and Safety of Dasatinib in Patients with Chronic Myeloid Leukemia in Blast Phase Whose Disease Is Resistant or Intolerant to Imatinib: 2-Year Follow-Up Data from the START Program. , 2007 .

[9]  L. Kearney,et al.  Blast crisis of chronic granulocytic leukemia with mast cell and basophilic precursors. , 1985, American journal of clinical pathology.

[10]  G. Popa,et al.  [Mast cell leukemia]. , 1977, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.